...
首页> 外文期刊>The Professional Medical Journal >HEPATITIS C VIRUS; Thru enzyme linked immuno-sorbant assay method in comparison to hepatitis c virus ribonucleic acid by polymerase chain reaction method
【24h】

HEPATITIS C VIRUS; Thru enzyme linked immuno-sorbant assay method in comparison to hepatitis c virus ribonucleic acid by polymerase chain reaction method

机译:丙型肝炎病毒;聚合酶链反应法与丙型肝炎病毒核糖核酸相比的酶联免疫吸附测定法

获取原文
           

摘要

Objectives: The plan of this current research was in the direction for towards theassessment of the existing ELISA (Enzyme Linked Immunosorbant Assay) method throughantibodies testing for identification of hepatitis C virus disease by comparing their outcome withthe Real Time polymerase chain reaction analysis. Setting: Peoples Medical College HospitalNawabshah. Period: December 2015 to December 2016. Methods: In this current research 100blood samples were analyzed due to the presence of anti-HCV antibodies by 3rd-generationenzyme-linked immunosorbent assay testing. All the specimens were 100% positive. Polymerasechain reaction test was performed according to the laboratory directions in anti- hepatitis C virusantibodies positive patients to validate the diagnosis of hepatitis C virus infectivity. Results: Thisresearch shows that, the entire results were positive by Enzyme Linked Immunosorbant Assaytesting. As compared with polymerase chain reaction the of Enzyme Linked ImmunosorbantAssay in this research the screening test for anti hepatitis C virus - antibodies is about 2%false positive. Out of the 100 samples 98 cases are positive by Real Time polymerase chainreaction analysis while only 02 cases report are negative (2%). Conclusion: The proportion ofhepatitis C virus infectivity was 100% by 3rd-generation enzyme-linked immunosorbent assaytesting, 98% by Real Time polymerase chain reaction analysis. As in our research the hepatitisC virus –Ribonucleic acid is present in 98% cases who are the Anti- hepatitis C virus antibodiespositive patients, it can be suggested that Anti-HCV antibodies detection by third generationELISA technique in routine procedure is sufficient to determine HCV infection.
机译:目的:本研究的方向是通过通过抗体检测将丙型肝炎病毒病与实时聚合酶链反应分析相比较的抗体测试,来评估现有的ELISA(酶联免疫吸附测定)方法。地点:人民医院纳瓦布夏。时间:2015年12月至2016年12月。方法:通过第三代酶联免疫吸附试验测试,由于抗HCV抗体的存在,本次研究分析了100个血液样本。所有标本均为100%阳性。根据实验室指导对抗丙型肝炎病毒抗体阳性的患者进行了聚合酶链反应测试,以验证丙型肝炎病毒感染性的诊断。结果:本研究表明,酶联免疫吸附试验的全部结果均为阳性。与聚合酶链反应相比,本研究中的酶联免疫吸附测定的抗丙型肝炎病毒抗体筛查率为2%假阳性。通过实时聚合酶链反应分析,在100个样本中有98例呈阳性,而只有02例呈阴性(2%)。结论:经第三代酶联免疫吸附试验检测,丙型肝炎病毒感染率为100%,实时聚合酶链反应分析为98%。正如我们的研究一样,在98%的抗丙型肝炎病毒抗体阳性患者中存在丙型肝炎病毒–核糖核酸,这表明在常规操作中通过第三代ELISA技术检测抗HCV抗体足以确定HCV感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号